Federal Register Notice: FDA’s collection of information entitled “Guidance for Industry on Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims,” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. To view this notice, click here.
